{"id":735,"date":"2023-05-24T10:11:29","date_gmt":"2023-05-24T01:11:29","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=735"},"modified":"2024-09-18T10:47:57","modified_gmt":"2024-09-18T01:47:57","slug":"2023-2","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/works\/2023-2\/","title":{"rendered":"2023"},"content":{"rendered":"\n

\uff08\u539f\u8457\u8ad6\u6587\uff09<\/strong><\/p>\n

    \n
  1. Gi T, Kuwahara A, Yamashita A, Matsuda S, Maekawa K, Moriguchi-Goto S, Sato Y, Asada Y. Histopathological features of cancer-associated venous thromboembolism: presence of intrathrombus cancer cells and prothrombotic factors. Arterioscler Thromb Vasc Biol. 2023;43:146-159. https:\/\/doi.org\/10.1161\/ATVBAHA.122.318463<\/a><\/li>\n
  2. Nakamura E, Maekawa K, Saito Y, Matsumoto T, Ogawa M, Komohara Y, Asada Y, Yamashita A. Altered choline level in atherosclerotic lesions: Upregulation of choline transporter-like protein 1 in human coronary unstable plaque. PLoS ONE. 2023;18;e0281730. https:\/\/doi.org\/10.1371\/journal.pone.0281730<\/a><\/li>\n
  3. Yamashita A, Oda T, Aman M, Wakasa T, Gi T, Ide R, Todo Y, Tamura N, Sato Y, Itoh H, Asada Y. Massive platelet-rich thrombus formation in small pulmonary vessels in amniotic fluid embolism: An autopsy study. BJOG. 2023;130:1685-1696. https:\/\/doi.org\/10.1111\/1471-0528.17532<\/a><\/li>\n
  4. Mochida K, Nakahata S, Suzuki Y, Inoue K, Moriguchi S, Yamashita A, Amano M, Morishita K. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations. J Dermatol Sci. 2023;109:80-88.<\/li>\n
  5. Kai K, Hamada T, Sato Y, Hiyoshi M, Imamura N, Yano K, Ikeda T, Ichihara A, Ogata S, Choijookhuu N, Hishikawa Y, Hosokawa A, Nanashima A. Extracellular volume fraction calculated using contrast enhanced computed tomography as a biomarker of oxaliplatin-induced sinusoidal obstruction syndrome: A preliminary histopathological analysis. J Oncol. 2023; 2023:1440257.<\/li>\n
  6. Kai K, Hiyoshi M, Imamura N, Hamada T, Yano K, Sato Y, Sakae T, Komi M, Nakamura T, Choijookhuu N, Hishikawa Y, Nanashima A. A preliminary pathological evaluation of extracellular volume fraction with contrast-enhanced computed tomography as a novel quantitative parameter of pancreatic fibrosis. Int Med. 2023; 62:1107-1115.\u00a0<\/li>\n
  7. Naoya Kuga, Takuro Shiiba, Tatsuhiko Sato, Shintaro Hashimoto, Yasuyoshi Kuroiwa. Experimental and computational verifications of the dose calculation accuracy of PHITS for high-energy photon beam therapy. Journal of Nuclear Science and Technology. 2023 (online published ahead of print). https:\/\/doi.org\/10.1080\/00223131.2023.2275737<\/li>\n<\/ol>\n

    \uff08\u75c7\u4f8b\u5831\u544a\uff09<\/strong><\/p>\n

      \n
    1. \u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u53f3\u5375\u7ba1\u75c5\u5909\u306e\u4e00\u4f8b. \u963f\u842c\u3000\u7d2b\u3001\u4e38\u585a\u6d69\u52a9\u3001\u4e2d\u539f\u4e00\u6210. \u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c. 2023;14:27-31.<\/li>\n
    2. \u751f\u4f53\u814e\u79fb\u690d\u5f8c\u306b\u5b50\u5bae\u9838\u90e8\u5c0f\u7d30\u80de\u795e\u7d4c\u5185\u5206\u6ccc\u764c\u3092\u767a\u75c7\u3057\u305f\u4e00\u4f8b. \u6c38\u8c37\u512a\u83ef\u3001\u4eca\u6751\u7d18\u5b50\u3001\u6751\u4e0a\u771f\u53cb\u3001\u611b\u5149\u3000\u78a7\u3001\u6751\u4e0a\u5b5f\u53f8\u3001\u9ad8\u6751\u4e00\u7d18\u3001\u963f\u842c\u3000\u7d2b\u3001\u8c37\u53e3\u79c0\u4e00\u3001\u5d8b\u672c\u5bcc\u535a. \u65e5\u672c\u5a66\u4eba\u79d1\u816b\u760d\u5b66\u4f1a\u96d1\u8a8c\u30002023;41:235-241.<\/li>\n
    3. \u80ba\u6c17\u7ba1\u652f\u306bSolitary fibrous tumor\u3068Intercalated duct hyperplasia\u306e\u5408\u4f75\u3092\u8a8d\u3081\u305f1\u4f8b. \u4f50\u85e4\u52c7\u4e00\u90ce, \u9ed2\u6728\u5c06\u82f1, \u524d\u7530 \u4eae, \u9b4f \u5cfb\u6d38, \u5c71\u4e0b \u7be4, \u6d45\u7530\u7950\u58eb\u90ce. \u8a3a\u65ad\u75c5\u7406. 2023;40:96-100.<\/li>\n
    4. \u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u9577\u671f\u5185\u670d\u306b\u3088\u308b\u591a\u767a\u6709\u68d8\u7d30\u80de\u764c\u306e\u6cbb\u7642\u4e2d\u306b\u751f\u3058\u305fMerkel\u7d30\u80de\u764c\u306e1\u4f8b. \u68ee \u611b\u83dc, \u6301\u7530\u8015\u4ecb, \u897f\u5ddd\u967d\u592a\u90ce, \u4e2d\u6751\u4fca\u592e, \u9b4f \u5cfb\u6d38, \u6cb3\u91ce\u5fb3\u660e, \u5929\u91ce \u6b63\u5b8f. \u81e8\u5e8a\u76ae\u819a\u79d1. 2023; 77:433-438.<\/li>\n
    5. \u518d\u767a\u3092\u7e70\u308a\u8fd4\u3057\u6025\u901f\u306b\u5897\u5927\u3057\u305f\u6bdb\u6bcd\u816b\u306e1\u4f8b. \u68ee\u3000\u611b\u83dc, \u5f8c\u7530\u512a\u9999, \u9577\u91ce\u3000\u611b\u5b9f, \u5927\u6817\u4f38\u884c, \u5929\u91ce\u6b63\u5b8f. \u76ae\u819a\u79d1\u306e\u81e8\u5e8a. 2023;65:1304-1305.<\/li>\n
    6. \u80f8\u817a\u764c\u539f\u767a\u306e\u8ee2\u79fb\u6027\u8108\u7d61\u819c\u816b\u760d\u306e1\u4f8b. \u5800\u4e4b\u5185\u307f\u3069\u308a, \u65e5\u9ad8\u8cb4\u5b50, \u67ca\u5c71\u3000\u5270, \u5927\u6817\u4f38\u884c, \u4f50\u85e4\u52c7\u4e00\u90ce, \u4e2d\u99ac\u79c0\u6a39, \u6c60\u7530\u5eb7\u535a. \u773c\u79d1\u81e8\u5e8a\u7d00\u8981. 2023;16:571-575.<\/li>\n
    7. \u4f50\u85e4\u52c7\u4e00\u90ce, \u963f\u842c\u3000\u7d2b, \u85e4\ufa11\u3000\u78a7, \u5409\u672c\u3000\u671b, \u5f8c\u85e4\u88d5\u78e8, \u5e73\u7530\u3000\u5fb9, \u6842\u6728\u771f\u53f8. Glassy cell carcinoma\u3068\u8a3a\u65ad\u3057\u3066\u3044\u305fAdenosquamous carcinoma\u306e1\u4f8b.\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c. 2023;14:69-72.<\/li>\n
    8. \u5c71\u672c\u54f2\u5e73, \u4e2d\u6751\u6075\u7406\u5b50, \u76db\u53e3\u6df8\u9999, \u5c71\u4e0b\u3000\u7be4, \u85e4\ufa11\u3000\u78a7, \u5927\u897f\u6df3\u4ec1, \u6842\u6728\u771f\u53f8, \u4f50\u85e4\u52c7\u4e00\u90ce.\u80ba\u816b\u760d\u585e\u6813\u75c7\u306b\u3088\u308a\u547c\u5438\u4e0d\u5168\u3092\u5448\u3057\u305f\u5b50\u5bae\u4f53\u90e8\u672a\u5206\u5316\u764c\u306e1\u5256\u691c\u4f8b. \u8a3a\u65ad\u75c5\u7406. 2023;40:242-247.<\/li>\n
    9. \u68ee \u611b\u83dc, \u897f\u5143\u9806\u5b50, \u5f8c\u7530\u512a\u9999, \u6301\u7530\u8015\u4ecb, \u963f\u842c \u7d2b, \u76db\u53e3\u6df8\u9999, \u5929\u91ce\u6b63\u5b8f. IgA \u514d\u75ab\u7d44\u7e54\u5316\u5b66\u7684\u67d3\u8272\u304c\u8a3a\u65ad\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u591a\u4e2d\u5fc3\u6027 Castleman \u75c5\u306e 1 \u4f8b. \u76ae\u819a\u81e8\u5e8a. 2023;65:1810-1814.<\/li>\n
    10. \u5c71\u4e0b\u9065\u5927, \u5bae\u7530\u660c\u660e, \u5ca9\u5207\u592a\u5e79\u5fd7, \u95a2\u6839\u96c5\u660e, \u5c3e\u672c\u548c\u4e5f, \u7a2e\u7530\u7a4d\u5b50, \u5c0f\u6c60\u6df3\u6a39, \u4e2d\u6751\u6075\u7406\u5b50, \u5c71\u4e0b\u7be4, \u4e45\u6c38\u4fee\u4e00. \u814e\u79fb\u690d6\u5e74\u5f8c\u306b\u767a\u75c7\u3057\u8a3a\u65ad\u306b\u96e3\u6e0b\u3057\u305fT\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e1\u4f8b. \u65e5\u672c\u81e8\u5e8a\u814e\u79fb\u690d\u5b66\u4f1a\u96d1\u8a8c. 2023;11:152-155.<\/li>\n
    11. \u91ce\u53e3\u88d5\u53f2\uff0c\u5fb3\u6e80\u8cb4\u5b50\uff0c\u68ee\u7530\u52dd\u4ee3\uff0c\u5cf0\u677e\u6620\u5b50\uff0c\u767d\u6ff1\u5e78\u751f\uff0c\u9ed2\u6728\u6804\u8f1d\uff0c\u524d\u5ddd\u548c\u4e5f\uff0c\u4f50\u85e4\u52c7\u4e00\u90ce. \u7570\u67d3\u6027\u7c98\u6db2\u69d8\u7269\u8cea\u3092\u8a8d\u3081\u305f\u985e\u4e0a\u76ae\u8840\u7ba1\u5185\u76ae\u816b\u306e1\u4f8b. \u65e5\u81e8\u7d30\u80de\u8a8c. (In press)<\/li>\n
    12. Gi T, Kuroiwa Y, Kihara Y, Miyaushiro S, Yamashita A. Magnetic resonance imaging of cancer-associated deep vein thrombus in a patient with gastric cancer. Circ Rep. 2023;5:265-266.<\/li>\n
    13. Maekawa K, Kuroki D, Hamada T, Kushima R, Sato Y, Yamashita A. Non-ampullary duodenal neoplasm of gastric phenotype showing multidirectional epithelial differentiation. Pathol Int. 2023;73:212-215.<\/li>\n
    14. Maekawa K, Nagayasu E, Hata Y, Hanamure F, Maruyama H, Yamashita A. Paragonimus westermani preadult fluke in a pulmonary necrotizing granulomatous lesion: A case associated with eating soy sauce-marinated raw freshwater crab, “gejang”. Pathol Int. 2023;73:373-376.<\/li>\n
    15. Shimazu H, Matsuura Y, Moribayashi K, Gi T, Suiko Y, Tanaka H, Komaki S, Ishikawa T, Yamashita A, Kaikita K. Very late stent thrombosis complicating immune thrombocytopenia: insights from optical coherence tomography and thrombopathology. JACC Case Rep. 2023;24:102017.<\/li>\n
    16. Tamura M, Yokogami K, Watanabe T, Kawano T, Muta J, Yamashita S, Oguri N, Sato Y, Takeshima H. PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma-a case report. Brain Tumor Pathol. 2023;40:40-44.<\/li>\n
    17. Inomata M, Kuroki S, Oguri N, Sato Y, Kawano F, Maeda R. Pleomorphic adenoma of the trachea: A case report. Int J Surg Case Rep. 2023;109:108499.<\/li>\n
    18. Kudo R, Kawaguchi T, Kimura M, Rikitake Y, Iwano C, Rikitake M, Iwao K, Aizawa A, Kariya Y, Matsuda M, Miyauchi S, Takajo I, Sato Y. Asada Y, Miyazaki T, Umekita K. Coronavirus disease 2019 in a patient with pulmonary fibrosis and emphysema: an autopsy report. Heliyon. 2023;9:e22221.<\/li>\n
    19. Inomata M, Kuroki S, Oguri N, Sato Y, Kawano F, Maeda R. Pleomorphic adenoma of the trachea: A case port. Int J Surg Case Rep. 2023 doi: 10.1016\/j.ijscr.2023.108499.<\/li>\n
    20. Arikawa S, Watanabe T, Yamaguchi H, Sato Y, Matsumoto F, Yokogami K, Takeshima H. Rare solitary pituitary metastasis of maxillary ameloblastic carcinoma: illustrative case. J Neurosurg Case Lessons. 2023;6:CASE23264.<\/li>\n
    21. Fujimoto K, Hisanaga S, Kuroda S, Kodama K, Sugiyama F, Kikuchi M, Kita T, Yamashita A, Nagai T, Kamimura T, Kaikita K, Imamura T, Fujimoto S. A case of primary aldosteronism with excessive secretion of renin that was unmasked by kidney transplantation. CEN Case Rep. doi: 10.1007\/s13730-023-00784-9. Online ahead of print.<\/li>\n
    22. Miyamoto Y, Kawasoe C, Ito K, Oguri N, Murashima T, Kamibeppu T, Nagai T, Takamori H, Kamimura T, Mukai S, Sato Y, Kamoto T. A case of hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma. JMCR (in press)<\/li>\n<\/ol>\n

      \uff08\u7dcf\u8aac\u306a\u3069\uff09<\/strong><\/p>\n

        \n
      1. Yamashita A, Asada Y. Underlying mechanisms of thrombus formation\/growth in atherothrombosis and deep vein thrombosis. Pathol Int. 2023;73:65-80. https:\/\/doi.org\/10.1111\/pin.13305<\/a><\/li>\n
      2. \u963f\u842c\u3000\u7d2b\u3001 \u82e5\u72f9\u670b\u5b50. \u7dcf\u8ad6\u3000\u6b7b\u56e0\u7a76\u660e\u306e\u305f\u3081\u306e\u75c5\u7406\u89e3\u5256\u306e\u91cd\u8981\u6027. \u5468\u7523\u671f\u533b\u5b66, 2023;53:301-305.<\/li>\n
      3. \u5c71\u4e0b\u3000\u7be4\u3001\u9b4f\u3000\u5cfb\u6d38. \u5fc3\u30a2\u30df\u30ed\u30a4\u30c9\u30fc\u30b7\u30b9, \u611f\u67d3\u6027\u5fc3\u5185\u819c\u708e, \u5fc3\u81d3\u7c98\u6db2\u816b. \u75c5\u7406\u3068\u81e8\u5e8a \u81e8\u6642\u5897\u520a\u53f7 \u75c5\u7406\u8a3a\u65ad\u30af\u30a4\u30c3\u30af\u30ea\u30d5\u30a1\u30ec\u30f3\u30b9. 2023;41: 2, 4, 8.<\/li>\n
      4. \u963f\u842c\u3000\u7d2b.\u3000\u80de\u72b6\u5947\u80ce, \u598a\u5a20\u9ad8\u8840\u5727\u75c7\u5019\u7fa4, Placental site nodule. \u75c5\u7406\u3068\u81e8\u5e8a \u81e8\u6642\u5897\u520a\u53f7 \u75c5\u7406\u8a3a\u65ad\u30af\u30a4\u30c3\u30af\u30ea\u30d5\u30a1\u30ec\u30f3\u30b9. 2023;41:174-176.\u00a0 \u00a0\u00a0<\/li>\n
      5. \u4f50\u85e4\u52c7\u4e00\u90ce. \u80ce\u76e4\u75c5\u7406\u3068\u8840\u6813\u306e\u610f\u7fa9. \u7523\u79d1\u3068\u5a66\u4eba\u79d1. 2023;90;1111-1115.6.\u00a0\u00a0\u00a0\u00a0<\/li>\n
      6. \u4f50\u85e4\u52c7\u4e00\u90ce. \u8868\u5c64\u578b\u306e\u7652\u7740\u80ce\u76e4. \u75c5\u7406\u3068\u81e8\u5e8a. 2023;41;881-883.<\/li>\n
      7. \u6d45\u7530\u3000\u7950\u58eb\u90ce.\u3000\u8840\u7ba1\u30fb\u8840\u6813\u306e\u75c5\u7406\u5f62\u614b\u7814\u7a76\u3092\u3075\u308a\u304b\u3048\u3063\u3066. \u8840\u6813\u6b62\u8840\u8a8c. 2023; 34: 58-60.<\/li>\n
      8. \u5c71\u4e0b\u3000\u7be4. \u6c38\u4e95\u4fe1\u592b. SPC\u5b66\u8853\u63a8\u9032\u59d4\u54e1\u4f1a\u6d3b\u52d5\u5831\u544a. \u8840\u6813\u6b62\u8840\u30e2\u30c7\u30eb\u90e8\u4f1a. \u8840\u6813\u6b62\u8840\u8a8c. 2023; 34: 698-700.<\/li>\n<\/ol>\n

        \uff08\u66f8\u7c4d\uff09
        <\/strong><\/p>\n